English | ÖÐÎÄ
News

Shanghai Pinnacles and Sysmex reached a strategic cooperation

2023/2/10 22:13:36¡¡Views£º529

Recently, Sysmex and Shanghai Pinnacles Medical Technology Co., Ltd. reached a strategic cooperation. Through Sysmex's mature channel network, this cooperation brings the combination of Pinnacles¡¯s KunLun series high-speed biochemical analyser and its assembly line and Sysmex product to the market. In the future, the two parties will utilise their respective advantages to integrate resources and improve product layout. The cooperation on the overall solution of biochemical immune diagnosis will be promoted to meet increasing clinical demand for high-speed biochemical analysers and intelligent diagnostics.

As a basic clinical diagnostic project, biochemistry has been highly mature in clinical application. However, in the context of clinical needs and centralised procurement policies, China is in a period of opportunity to upgrade from medium-speed biochemical analysers to high-speed biochemical analysers. The high-speed biochemical analysers has multiple highlights such as faster speed, efficient system operation and accurate results. With the continuous advancement of centralised procurement, the high-speed biochemical analysers meets the needs of public hospitals for cost reduction and efficiency promotion. The data shows that the compound annual growth rate of my country's domestic high-speed biochemical instruments is more than 10%. The high-speed biochemical analysers and its assembly lines have became new trends in the Chinese IVD market.

 

Zuohui PENG, global executive director of Sysmex Group, said: "Sysmex lacks high-speed biochemical analysers in the field of biochemical immunoassay. By introducing a localised high-speed biochemical analysis system and intelligent assembly line, combined with Sysmex's high-sensitivity immunochemiluminescence diagnostic system, an overall biochemical immune assembly line is formed to meet the needs of the Chinese public hospital. " 

"The years of cooperation with Mr. Wei DING, the founder of Pinnacles, has given us a good foundation of trust. Mr. Ding Wei has excellent integration and execution capabilities. After repeated and strict performance evaluations by Sysmex, Pinnacles's products have excellent performance. In addition, we also value the industrialisation experience and potential R&D capabilities of Pinnacles team, which can ensure iterative product upgrades. I believe that combining the services of both parties can provide customers with reliable after-sales guarantee. At present, the cooperation with Pinnacles is progressing very quickly and smoothly, and the products have been jointly promoted to be installed and used by many customers. ¡° 


Wei Ding, the founder and chairman of Pinnacles, said: "Precise medicine begins with precise diagnosis. The Chinese IVD market is growing at a rate of more than 10% every year, and has a broad space for development. At present, the continues pursuit of high-quality and cost-effective products has brought the Chinese IVD market into a new period of reshuffle. I believe that the intelligent diagnostics is the new trend of the IVD field, and currently Pinnacles is building an 'unattended laboratory'. In the future, platform integration and extensive cooperation will be the key of IVD companies. The cooperation between Pinnacles and Sysmex is not a simple cooperation between manufacturers and agents, but to jointly build an ecosystem.¡±